Detalhe da pesquisa
1.
HER2 mutation as an emerging target in advanced breast cancer.
Cancer Sci
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715247
2.
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach-part I: prognostic factors and indications to treatment.
Radiol Med
; 129(1): 160-173, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37731151
3.
Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.
Acta Oncol
; 62(11): 1440-1450, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37801288
4.
Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations.
Radiol Med
; 128(8): 1007-1021, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37415056
5.
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation.
Radiol Med
; 128(3): 362-371, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877421
6.
Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration.
Int J Mol Sci
; 23(23)2022 Nov 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36498861
7.
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Lancet Oncol
; 22(5): 727-736, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862002
8.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859534
9.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
10.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330065
11.
Predictive classifier for intensive treatment of head and neck cancer.
Cancer
; 126(24): 5263-5273, 2020 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33017867
12.
Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives.
Int J Mol Sci
; 21(10)2020 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32429381
13.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536609
14.
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
J Cell Physiol
; 233(3): 2313-2323, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28710865
15.
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting.
J Transl Med
; 16(1): 129, 2018 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29769125
16.
[The impact of Reiki on side effects in patients with head-neck neoplasia undergoing radiotherapy: a pilot study]. / L'impatto del Reiki sugli effetti collaterali nei pazienti con neoplasia testa-collo in trattamento radioterapico: uno studio pilota.
Prof Inferm
; 70(3): 214-221, 2017.
Artigo
em Italiano
| MEDLINE | ID: mdl-29460558
17.
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
J Cell Physiol
; 231(11): 2541-7, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27187274
18.
Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia.
Strahlenther Onkol
; 190(11): 1001-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24756139
19.
HPV-related oropharyngeal carcinoma with Overt Level II and/or III metastases at presentation: The risk of subclinical disease in ipsilateral levels IB, IV and V.
Acta Oncol
; 53(5): 662-8, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24274389
20.
Quality of Life Longitudinal Evaluation in Prostate Cancer Patients from Radiotherapy Start to 5 Years after IMRT-IGRT.
Curr Oncol
; 31(2): 839-848, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38392056